Advances in carbon nanotubes for malignant melanoma: a chance for treatment


Butantan affiliation
Publication type
Article
Language
English
Appears in Collections:
Metrics
Abstract
Malignant melanoma is an aggressive skin cancer with limited therapeutic options. Cancer is the second largest cause of death in society and one of the most difficult diseases to treat. Advances in biotechnology have enabled the current use of nanotechnology via the application of nanomaterials, especially as drug delivery systems for the transportation of very small particles. In this context, carbon nanotubes, with a potential role in the diagnosis and treatment of melanoma, are still an emerging research field. Their properties have been extensively studied for the use of antineoplastics drugs, as well as for DNA and RNA interference for the treatment of cancer. However, the most important challenge in nanomedicine is to decrease the toxicity and increase the biocompatibility of the nanomaterials used to transport therapeutic molecules. In this sense, this article addresses the recent advances in the use of carbon nanotubes in melanoma therapy and highlights the opportunities and challenges in this area. The advances and challenges involving these topics are essential to the success of nanoconjugate systems, and studies improving the comprehension of these nanosystems contribute to the development of specific antitumor therapies.
Reference
Lima ENC, Piqueira JRC, Maria DA. Advances in carbon nanotubes for malignant melanoma: a chance for treatment. Mol. Diagn. Ther.. 2018 Dec;22(6):703-15. doi:10.1007/s40291-018-0363-7.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/2618
Issue Date
2018

Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.